• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XIONG Lun, GUAN Dongliang, LI Jian, HUANG Wei. Synthetic process of telavancin[J]. Journal of China Pharmaceutical University, 2017, 48(2): 172-177. DOI: 10.11665/j.issn.1000-5048.20170207
Citation: XIONG Lun, GUAN Dongliang, LI Jian, HUANG Wei. Synthetic process of telavancin[J]. Journal of China Pharmaceutical University, 2017, 48(2): 172-177. DOI: 10.11665/j.issn.1000-5048.20170207

Synthetic process of telavancin

More Information
  • New process reported the synthesis of telavancin using decyl alcohol as the starting material. After methanesulfonylation, nucleophilic substitution with ethanolamine, Fmoc protection, and Parikh-Doering oxidation, the intermdiate N-(9-fluorenyl-9-methoxycarbonyl)decylaminoethyl acetaldehyde( 5 )was obtained. Vancomycin hydrochloride and intermediate 5 were then subject to reductive amination reaction, Fmoc deprotection, and Mannich reaction to give the telavancin product. The process have been deeply studied on the two key reactions of reductive amination and Mannich reaction, and the reaction conditions have been optimized. The overall yield is 46% based on starting material vancomycin.
  • [1]
    Chang MH,Kish TD,Fung HB.Telavancin:a lipoglycopeptide antimicrobial for the treatment of complicated skin and skin structure infections caused by Gram-positive bacteria in adults[J].Clin Ther,2010,32(13):2160-2185.
    [2]
    Karlowsky JA,Nichol K,Zhanel GG.Telavancin:mechanisms of action,in vitro activity,and mechanisms of resistance[J].Clin Infect Dis,2015,61(Suppl 2):S58-S68.
    [3]
    Hegde SS, Janc JW. Efficacy of telavancin, a lipoglycopeptide antibiotic,in experimental models of Gram-positive infection[J].Expert Rev Anti-Infe,2014,12(12):1463-1475.
    [4]
    Higgins DL,Chang R,Debabov DV,et al.Telavancin,a multifunctional lipoglycopeptide,disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus[J].Antimicrob Agents Chemother,2005,49(3):1127-1134.
    [5]
    Lee J, Liu J. Process for preparing glycopeptide phosphonate derivatives:US,7074890[P].2004-08-25[2016-04-04] .
    [6]
    Leadbetter MR.Glycopeptide phosphonate derivatives:US,8541375[P].2011-12-16[2016-04-04] .
    [7]
    Liang YH, Feng WH. Process improvement on the synthesis of lipoglycopeptide antibiotic telavancin[J].Chin J Synt Chem(合成化学),2011,19(4):550-553.
    [8]
    Ma S,Jia CY,Yuan H,et al.Synthesis of telavancin[J].Chin J New Drugs(中国新药杂志),2013,23(23):2809-2812.
    [9]
    Benito-Garagorri D. Process for the synthesis of telavancin, its pharmaceutically acceptable salts as well as an N-protected imine-derivative of telavancin:WO,2013034676[P].2011-09-09[2016-04-04] .
    [10]
    Li XP,Wu JP,Liang XM,et al.Application of DMSO as oxidant in organic syntheses[J].Chin J Org Chem(有机化学),2001,21(8):549-556.
    [11]
    Tidwell TT.Oxidation of alcohols by activated dimethyl sulfoxide and related reactions:an update[J].Synthesis,1990(10):857-870.DOI: 10.1002/chin.199112358.
    [12]
    Parikh JR,Doering WE.Sulfur trioxide in the oxidation of alcohols by dimethyl sulfoxide[J].J Am Chem Soc,1967,89(21):5505-5507.
  • Related Articles

    [1]LIU Li, LIU Zijin, TANG Jun, HE Guangwei, LIU Weizhong. Optimized synthesis process of tofacitinib citrate[J]. Journal of China Pharmaceutical University, 2022, 53(6): 685-689. DOI: 10.11665/j.issn.1000-5048.20220606
    [2]WU Xufeng, CHAI Shiying, LIU Jianhong, WANG Zhihui, YIN Ruifeng, CAO Ruiwei, SUN Xinqiang. Improvement of synthetic route of brivudine[J]. Journal of China Pharmaceutical University, 2022, 53(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20220106
    [3]WANG Dong, ZHONG Jian, WANG Ling, ZHOU Zhihui, JIANG Haiting, LUO Peng, WANG Xizhi, WANG Chongyi. Improved synthetic process of apremilast[J]. Journal of China Pharmaceutical University, 2021, 52(5): 536-540. DOI: 10.11665/j.issn.1000-5048.20210504
    [4]HAN Chengqun, ZOU Qiaogen, SUN Qian, XIA Yunyan. Improvement of synthesis process of mirabegron[J]. Journal of China Pharmaceutical University, 2020, 51(4): 449-453. DOI: 10.11665/j.issn.1000-5048.20200409
    [5]ZHANG Qiuyue, YOU Qidong, YANG Jinpeng. Process improvement on the synthesis of atomoxetine[J]. Journal of China Pharmaceutical University, 2019, 50(4): 405-409. DOI: 10.11665/j.issn.1000-5048.20190404
    [6]LIU Li, WANG Chen, LIU Lixin, JI Tingting. Improved synthesis of analgesic pentazocine[J]. Journal of China Pharmaceutical University, 2018, 49(5): 568-571. DOI: 10.11665/j.issn.1000-5048.20180508
    [7]MA Li, ZHANG Menghan, XU Zhiwei, SUN Ying′ai, ZHU Jing, HUANG Yingbo, ZHANG Dayong. A new synthetic process of dapagliflozin[J]. Journal of China Pharmaceutical University, 2017, 48(1): 42-45. DOI: 10.11665/j.issn.1000-5048.20170106
    [8]WEI Qingjie, QIAO Junhua, CHEN Jianjun, GAO Zhigang, LI Yaqing. An improvement for synthesis of ceftriaxone sodium[J]. Journal of China Pharmaceutical University, 2016, 47(2): 163-165. DOI: 10.11665/j.issn.1000-5048.20160206
    [9]Improve on the Synthetic Process of Bezafibrate[J]. Journal of China Pharmaceutical University, 2003, (3): 80-81.
    [10]Improved Process of Nimodipine[J]. Journal of China Pharmaceutical University, 1998, (3): 82-83.
  • Cited by

    Periodical cited type(3)

    1. 李雨晴,邹师琪,傅伟淇,杨欣. 基于网络药理学和分子对接探讨陈皮治疗非小细胞肺癌的作用机制. 中华生物医学工程杂志. 2024(04): 266-272 .
    2. 高杰,丁留成,卫中庆. 脂质代谢在去势抵抗性前列腺癌中的研究进展. 东南国防医药. 2021(02): 169-174 .
    3. 赵帅华,董卫红,杨敬,韩保卫. ABHD5过表达对结肠癌细胞侵袭、迁移及AMPK/mTOR通路的影响. 中国普外基础与临床杂志. 2021(07): 850-855 .

    Other cited types(2)

Catalog

    Article views PDF downloads Cited by(5)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return